NIDA - Research Monographs - Monograph 150: Integrating Behavioral Therapies With Medications in the Treatment of Drug Dependence

[Finished Printing? - Click Here to Return to Normal View]

	NIDA Home > Publications > Research Monographs >
	Integrating Behavioral Therapies With Medications in the Treatment of Drug Dependence

NIDA Research Monograph, Number 150 [Printed in 1995]

If you have the Acrobat reader plug-in for Netscape or Internet Explorer click on the document link and you will be able to view and/or print out the pages. If you have trouble viewing the document in your browser window, download the document (Windows users - right click on the link and Save as...) to your computer and get Adobe Acrobat Reader (free) in order to view it.

This monograph is not available by chapter. The Table of Contents (below) is shown to assist in locating information prior to downloading the monograph.

Download Monograph150.pdf - Integrating Behavioral Therapies With Medications in the Treatment of Drug Dependence (576 KB)

Table of Contents

Medications and Behavioral Therapies: The Whole May Be Greater Than the Sum of the Parts-----1
Lisa Simon Onken, Jack D. Blaine, and John J. Boren

Enhancing the Effectiveness of Methadone Using Psychotherapeutic Interventions-----5
Charles P. O’Brien, George E. Woody, and A. Thomas McLellan

Integrating Psychotherapy and Pharmacotherapy for Cocaine Dependence: Results From a Randomized Clinical Trial-----19
Kathleen M. Carroll, Bruce J. Rounsaville, Charla Nich, Lynn Gordon, and Frank Gawin

Can Psychotherapy Rescue Naltrexone Treatment of Opioid Addiction?-----37
Bruce J. Rounsaville

Strategies To Maximize the Efficacy of Naltrexone for Alcohol Dependence-----53
Stephanie S. O‘Malley

Disulfiram (Antabuse) Contracts in Treatment of Alcoholism-----65
Timothy J. O’Farrell, John P. Allen, and Raye Z. Litten

Combining Behavioral Therapy and Pharmacotherapy for Smoking Cessation: An Update-----92
John R. Hughes

Integrating Psychological and Pharmacological Treatment of Dually Diagnosed Patients-----110
Roger D. Weiss, Shelly F. Greenfield, and Lisa M. Najavits

Combining Pharmacotherapy With Psychotherapy for Substance Abusers With Borderline Personality Disorder: Strategies for Enhancing Compliance-----129
Marsha M. Linehan

Integration of Behavioral and Pharmacological Treatments for Panic Disorder: Implications for the Treatment of Substance Dependence-----143
Michael W. Otto, Murk H. Pollack, Susan G. Ball, and Jerrold F. Rosenbaum

Some Methodological Comments-----167
Kenneth I. Howard

Comments-----170
Stephen T. Higgins

Advanced Search \| FAQs \| Accessibility \| Site Map \| Help \| NIDA Home \| Privacy Policy \| FOIA (NIH) \| Employment \| Print Version
	The National Institute on Drug Abuse (NIDA) is part of the National Institutes of Health (NIH), a component of the U.S. Department of Health and Human Services. Questions? See our Contact Information. Last updated on Wednesday, September 18, 2002.